Niacin as a novel therapy for septic shock?

Crit Care Med. 2011 Feb;39(2):410-1. doi: 10.1097/CCM.0b013e318205c05e.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Disease Models, Animal
  • Down-Regulation
  • Endotoxemia / drug therapy
  • Endotoxemia / genetics
  • Endotoxemia / mortality
  • Female
  • Humans
  • Male
  • NF-kappa B / drug effects*
  • Niacin / therapeutic use*
  • Pneumonia / drug therapy*
  • Pneumonia / mortality
  • Pneumonia / prevention & control
  • Rats
  • Sensitivity and Specificity
  • Shock, Septic / drug therapy*
  • Shock, Septic / genetics
  • Shock, Septic / mortality
  • Signal Transduction
  • Survival Rate
  • Treatment Outcome

Substances

  • NF-kappa B
  • Niacin